newsfilter
← Latest News
Business Wire·

Aditxt and Evofem Amend and Restate Merger Agreement, Targeting September 30 Closing

Evofem Acquires SOLOSEC, an FDA-Approved Single-Dose Treatment for Bacterial Vaginosis and Trichomoniasis Aditxt, Inc. ("Aditxt") (NASDAQ:ADTX), a company dedicated to discovering, developing, and deploying promising